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            Atrial Fibrillation (AF) affects approximately five million people world- wide. The 
incidence of AF increases with aging and more common in males.1 Atrial fibrillation is the most 
common cardiogenic cause of stroke and exacerbates heart failure. Despite the prevalence of AF, 
it is still one of the most difficult arrhythmia to treat.2 The management option of AF ranges 
from pharmacological therapy, catheter based ablation and surgery. However, non-traditional 
uses   of   pacemaker   therapy   have   been   reported   in   recent   past.
            Pacing therapies for AF are specific to the nature of the patient's AF. 3,4 Pharmacological 
management alone is the typical initial course of action. In AF cases where rapid ventricular 
rates cannot be controlled by pharmacological therapy, ventricular pacing therapy may be 
combined   with   radiofrequency   catheter   ablation   of   AV   node.  5
            An atrial based pacing mode compared with ventricular pacing, results in better clinical 
and hemodynamic conditions for patients with ventricular dysfunction.6 Rosenqvist M et al7 
demonstrated that ventricular based pacing is associated with abnormal activation (e.g., pre-
excitation) patterns that adversely affect cardiac hemodynamics. Specially, cardiac output and 
peak ventricular filling rates were found to be significantly lower in ventricular paced groups as 
compared to atrial based pacing groups. As well, lower peak oxygen uptake levels and oxygen 
saturation levels were found in ventricular paced groups. Similarly, Vardas et al 8 compared 
DDD and AAI pacing modes and concluded that atrial based pacing, at rest, produces a 
significantly greater cardiac output as compared to the DDD mode. However, no differences 
were   found   between   the   pacing   modes   during   increased   heart   rates.
            Atrial overdrive pacing therapy for patients with paroxysmal AF is done with the intent 
of altering or controlling AF.  9  Initiation of AF can be affected by suppressing the atrial 
premature beats that typically triggers or by modifying their propagation. The mean heart rate 
just before the onset of an AF episode is slightly higher than at rest and is very difficult to 
observe in most instances. This makes AF difficult to predict and monitor using pacing 
technology. Consequently, continuous overdrive atrial pacing is proposed to be a good course of 
treatment. The theoretical basis for overdrive pacing is the idea to continuously pace the atrium 
at higher rate than the patient sinus rate, so that it could alter the intrinsic atrial rate, propagation 
and   suppress   automaticity,   caused   by   electrical   remodeling,   in   the   diseased   fibers.  10
            The case report by Levine et al 11 in this issue has discussed the utility of this therapy in 
a symptomatic patient with additional sinus node dysfunction, who was intolerant to the 
pharmacological therapy. The patient was marked symptomatic with paroxysmal AF and 
medical therapy, which got remarkably subsided with DDD pacing and withdrawal of medicine, 
however, the episodes of paroxysmal AF reduced after atrial fibrillation suppression algorithm.
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            The AF suppression algorithm is a newly approved algorithm designed to provide a high 
percentage of atrial overdrive pacing, which control the atrial rate, either from the sinus node or 
an ectopic foci. The objective is reduced temporal dispersion of the atrial refractory period 
combined   with   overdrive   suppression   of   ectopic   beats,   a   common   trigger   for   atrial 
tachyarrhythmias. Automatic mode switch (AMS) remains functional with the AF Suppression 
algorithm on, thus if AF occurs, AMS is activated facilitating management as this provides 
information   as   to   the   frequency   and   duration   of   each   AMS   episode.  
            While the algorithm may not be 100% effective in all patients, any reduction in the 
number of AF episodes is beneficial. The use of a pacemaker containing the AF suppression 
algorithm should be considered in all patients undergoing device implant for a symptomatic 
bradycardia, particularly when there is a prior history of atrial fibrillation or they are at risk of 
AF   which  is   more   likely   when  the  indication   for   pacing  is   sinus   node   dysfunction.  
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